TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
JSPR

Jasper Therapeutics Inc

Healthcare · Biotechnology

0.6229$ +0.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Balance Sheet

Jasper Therapeutics Inc (JSPR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 12 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet JSPR
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
110 95 126 114 99 80 58 46 57 36 21 12
105 89 120 109 95 76 53 43 55 35 20 12
104 87 118 107 93 72 49 40 51 29 14 7.3
104 87 118 107 93 72 49 40 51 29 14 7.3
0.3 0.3 0.3 0.3 0.3
0.7
16 16 13 14 16 18 15 23 46 32 18 10
12 12 8.9 10 12 15 12 21 21 13 9.0 7.8
0.9 1.0 1.0 1.0 1.1 1.1 1.8 2.0 1.7 1.2 0.8 0.3
3.3 4.1 2.4 3.0 3.1 4.0 3.0 8.0 9.2 6.2 2.4 2.8
94 78 113 100 84 62 42 24 12 4.2 3.4 1.4
-153 -170 -183 -198 -217 -241 -262 -289 -308 -317 -318 -321
11 11 13 15 15 15 15 15 17 29 29 29

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?